Global Biopharmaceuticals Manufacturing Consumables Testing Market to Reach $1.1 Billion by 2030
The global market for Biopharmaceuticals Manufacturing Consumables Testing estimated at US$549.3 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2023-2030. Compendial & Multi Compendial Laboratory Testing, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$573.6 Million by the end of the analysis period. Growth in the Laboratory Testing segment is estimated at 11.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $143.2 Million, While China is Forecast to Grow at 14.5% CAGR
The Biopharmaceuticals Manufacturing Consumables Testing market in the U.S. is estimated at US$143.2 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$267.5 Million by the year 2030 trailing a CAGR of 14.5% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 9.1% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$180 Million by the year 2030.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook